Monitoring disease progression in metabolic dysfunction-associated steatotic liver disease.
Nabil NoureddinNedret Copur-DahiStephen CaldwellPublished in: Alimentary pharmacology & therapeutics (2024)
Various biomarkers can be used in different care settings to monitor disease progression. Further research is needed to validate noninvasive tests more effectively.